• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • New CNAS Accreditation for Group Enterprise Internal Laboratories Explained

New CNAS Accreditation for Group Enterprise Internal Laboratories Explained

Saturday, 26 February 2022 / Published in Medical Device, News, NMPA Registration in China

New CNAS Accreditation for Group Enterprise Internal Laboratories Explained

On January 12, 2022, the CNAS (China National Accreditation Service for Conformity Assessment) issued the CNAS-EL-21: 2022 to provide guidance for applying for the accreditation for group enterprise internal laboratories. The regulatory instructions will come into effect on March 1, 2022.

Scope

  • The core business function of group enterprise internal laboratories should be testing products and related raw materials that are manufactured internally.
  • Headquarters of the group enterprise should have its own laboratory operating independently.

Conditions of Accreditation

  • The group enterprise internal laboratories should be operated for a minimum duration of 5 years under a constantly improving management system.
  • Before applying for the accreditation as group enterprise internal laboratories, the enterprise should have a minimum of 10 laboratories in total, including laboratories of the headquarters and subsidiary companies, that must be CNAS accredited already.
  • The group enterprise internal laboratories should have a clear organization structure, and have responsibilities, authorities and interrelationships clearly defined for each management level. The headquarters of the group enterprise or its main laboratory should establish a quality evaluation system for the subsidiary laboratories involved.

Once the accreditation for group enterprise internal laboratories is obtained, manufacturers can facilitate synergy for business operations and meeting regulatory requirements, including self-tests, in China. (More information about self-testing requirements available in our previous blog post).

By Julie Zhang and Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: CNAS accreditation, Self-testing

What you can read next

Public Consultation for the Directory of Claimed Health Functions Permitted for Health Food (I)(2019)
SAMR implements Administrative Measures for Product Quality Spot Inspections and Consumer Goods Recall Management for 2020
NMPA Essential Principles of Safety and Performance of Medical Devices

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.